Glucoregulation in normal weight schizophrenia patients treated by first generation antipsychotics

Srpski Arhiv za Celokupno Lekarstvo

Volumn 136, Issue 3-4, 2008, Pages 110-115

  Marić, Nada ^a   Doknić, Mirjana ^a   Damjanović, Aleksandar ^a   Pekić, Sandra ^a   Jašović Gašić, Miroslava ^a   Popović, Vera ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Antipsychotics; Diabetes; Glucose; Growth hormone; Insulin; Schizophrenia

Indexed keywords

GLUCOSE; INSULIN; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BLOOD; BODY MASS; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; METABOLISM; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; SCHIZOPHRENIA;

EID: 52049089664     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH0804110M     Document Type: Article

References (19)

1. Zimet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: A global public health problem and a new definition. J Atheroscler Tromb 2005; 12:295-300.
2. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. American Diabetes Association. Diabetes Care 2004; 27(2):596-601.
3. Kinon B, Basson B, Gilmore J, et al. Long term olanzapine treatment: weight change and weight related health factors in schizophrenia. J Clin Psyciatry 2001; 62:92-100.
4. Tarricone I, Casoria M, Ferrari B, et al. Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a community mental health centre. BMC Psychiatry 2006; 6:1-8.
5. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13(2):261-276.
6. Grottoli S, Gasco V, Ragazzoni F, Ghigo E. Hormonal diagnosis of growth hormone hypersecretory states. J Endocrinol Invest.2003; 26(10):27-35.
7. Misra M, Miller K, Herzog DB, et al. Growth hormone and ghrelin responses to an oral glucose load in adolscent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 2004; 89(4):1605-1612.
8. Newcomer JW, Haupt DW, Fucetola R, et al. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 2002; 59:337-345.
9. Gianfrancesco FD, Grogg AL, Mahmoud RA, et al. Differential effects of risperidone, olanzapine, clozapine and conventional antipsychotics on type 2 diabetes: findings from the large health database. J Clin Psychiatry 2002; 63:920-930.
10. Buse JB, Cavazzoni P, Hornbuckle K, et al. A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States. J Clin Epidemiology 2003; 56:164-170.
11. Holt RI, Bushe C, Citrome L. Diabetes and schizophrenia 2005: Are we any closer to understand the link? J Psychopharmacol 2005; 19:56-65.
12. Cohen D, Stolk RP, Grobbee DE, Gispen de Wied CC. Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders. Diabetes Care 2006; 29(4):786-791.
13. Henderson DC, Caglliero E, Copeland PM, et al. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psichiatry 2005; 62(1):19-28.
14. Melkersson KI, Dahl ML. Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses. Psychopharmacology (Berl) 2003; 170:157-166.
15. Ryan M, Collins P, Thakore J. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003; 160:284-289.
16. Mukherjee S, Decina P, Bocola V, Saraceni F, Scapichio PL. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996; 37:68-73.
17. Bergman RN, Ader M. Atypical antipsychotics and glucose homeostasis. J Clin Psychiatry. 2005; 66(4):504-514.
18. Ader M, Kim S, Hucking K, Kabir M, Bergman RN. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease. Diabetes 2005; 54:862-871.
19. Peters A, Schweiger U, Pellerin L, et al. The selfish brain: competition for energy resources. Neurosci Biobehav Rev 2004; 28(2):143-180.